UPDATE: H.C. Wainwright Starts Salarius Pharmaceuticals (SLRX) at Buy
Tweet Send to a Friend
(Updated - August 25, 2021 6:54 AM EDT)
H.C. Wainwright analyst Michael King initiates coverage on Salarius Pharmaceuticals (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
H.C. Wainwright analyst Michael King initiates coverage on Salarius Pharmaceuticals (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
